Isoproterenol Regulates Lipopolysaccharide-Induced Tumor Necrosis Factor-Alpha and Interleukin-6 Production in Monocytes from Essential Hypertensive Patients

Youyi Zhang
2007-01-01
Abstract:Objective:To investigate the effects of β-adrenoceptor agonist isoproterenol(ISO) on lipopolysaccharide(LPS) induced inflammatory cytokine-tumor necrosis factor-alpha(TNF-α) and interleukin-6(IL-6)] in monocytes from essential hypertensive patients (Stage I). Methods: Monocytes were isolated from 17 healthy volunteers and 6 hypertensive patients’ venus blood, and the monocytes were cultured with LPS (0.2 μg/L) and ISO. The concentrations of TNF-α and IL-6 in the cultured supernatant were measured with enzyme-linked immunosorbent assays. Results: (1) TNF-α production induced by LPS in monocytes from hypertensive group were higher than those from control group [(1 897±393) ng/L vs. (975±473) ng/L, P0.01]. But the differences of IL-6 production were not significant between the two groups [(5 532±796) ng/L vs. (6 092±2 249) ng/L, P0.05]. (2) ISO inhibited extracellular TNF-α production induced by LPS in a dose-dependent manner. The inhibitory effects were ameliorated by β-adrenoceptor antagonist propranolol. In contrast, ISO had no effect on the production of IL-6 induced by LPS. The difference of inhibitory effects of ISO on TNF-α production was not statistically significant between hypertensive group and healthy control group (P0.05). Conclusion: β-adrenergic activation inhibits TNF-α (but not IL-6) production induced by LPS in monocytes. The inhibitory effects were not different between early staged hypertensive patients and healthy subjects.
What problem does this paper attempt to address?